TF
AUPH icon

TimeScale Financial’s Aurinia Pharmaceuticals AUPH Stock Holding History

TimeScale Financial’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$620 Hold
64
– – ﹤0.01% 566
2023
Q1 		$701 Hold
64
– – ﹤0.01% 552
2022
Q4 		$481 Hold
64
– – ﹤0.01% 538
2022
Q3 		$0 Hold
64
– – ﹤0.01% 543
2022
Q2 		$1K Hold
64
– – ﹤0.01% 448
2022
Q1 		$1K Hold
64
– – ﹤0.01% 470
2021
Q4 		$1K Buy
+64
New +$1.52K ﹤0.01% 468

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TimeScale Financial's AUPH Position: Q2 2023 in Review

TimeScale Financial held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2023 at 64 shares worth $620. The position accounts for ﹤0.01% of the portfolio, ranked #566.

TimeScale Financial first reported a position in AUPH in Q4 2021 and has held it in 7 quarters since. The position peaked at $1K in Q2 2022. 200 funds tracked by Wall St. Rank hold AUPH as of Q2 2023.

  • TimeScale Financial held 64 shares of Aurinia Pharmaceuticals worth $620 as of Q2 2023.
  • TimeScale Financial left its Aurinia Pharmaceuticals share count unchanged in Q2 2023.
  • Aurinia Pharmaceuticals made up ﹤0.01% of TimeScale Financial's portfolio in Q2 2023, its #566 holding.
  • TimeScale Financial first reported a position in Aurinia Pharmaceuticals in Q4 2021 and has held it in 7 quarters since.
  • TimeScale Financial's Aurinia Pharmaceuticals position peaked at $1K in Q2 2022.
  • 200 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.